Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-743-4 | CAS number: 13472-45-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-03-09 to 1999-06-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Performed per OECD Guideline 401, Acute Oral Toxicity and GLP.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Disodium wolframate
- EC Number:
- 236-743-4
- EC Name:
- Disodium wolframate
- Cas Number:
- 13472-45-2
- Molecular formula:
- Na2WO4
- IUPAC Name:
- disodium dioxotungstenbis(olate)
- Details on test material:
- - Name of test material (as cited in study report): Sodium Tungstate Dihydrate
- Physical state: White powder
- Analytical purity:99.9%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd, Bicester, Oxon, England.
- Age at study initiation: 4 to 7 wks
- Weight at study initiation: 87 to 125 g
- Fasting period before study: Overnight
- Housing: In groups of 5 rats of the same sex in metal cages with wire mesh floors.
- Diet: ad libitum- standard laboratory rodent diet (Special Diet Services RM1(E) SQC expanded pellet)
- Water: ad libitum
- Acclimation period:5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 22.5 C
- Humidity (%): 29 to 59 %
- Air changes (per hr): 10 to 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: March 9, 1998 To: April 14, 1998
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
-
MAXIMUM DOSE VOLUME APPLIED: 800, 1260, and 2000 mg/kg Bodyweight
- Doses:
- Animals were exposed at a fixed dose volume of 10 mL/kg bodyweight.
800 mg/kg (dose concentration 8 mg/mL).
1260 mg/kg (dose concentration of 12.6 mg/mL)
2000 mg/kg (dose concentration of 20 mg/mL). - No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Mortalities: Cages of rats were checked at least twice daily for mortalities.
- Clinical signs: Animlas were observed soon after dosing and at frequent intervals for the remainder of Day 1. On subsequent days, surviving animals were observed once in the morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature of the clinical signs and time were recorded at each observation. All animals that survived treatment were observed for 14 days after dosing.
- Body weights: Body weights of each rat was recorded on Days 1 (prior to dosing), 8 and 15 or at death. Individual weekly body weight changes and group mean body weights were calculated.
- Necropsy of survivors performed: yes
-Macroscopic pathology: All animals were subjected to macroscopic examination which consisted of opening the cranial, abdominal and thoracic cavities. The macroscopic appearance of all tissues was recorded.
- Other examinations performed: histopathology
- Statistics:
- The acute median lethal oral dose (LD50) to male and female rats was calculated using the method of Finney (1971).
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 539 mg/kg bw
- 95% CL:
- 1 206 - 1 965
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 373 mg/kg bw
- 95% CL:
- 1 174 - 1 607
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 453 mg/kg bw
- 95% CL:
- 1 221 - 1 729
- Mortality:
- All rats dosed at 2000 mg/kg and one female dosed at 1260 mg/kg died during the study. The majority of deaths occurred within the first six hours following dosing with a lesser number of rats expiring between approximately 24 and 48 hrs. after dosing.
- Clinical signs:
- other: Piloerection was observed in all rats within 6 min. of dosing. This sign persisted and was accompanied later on Day 1 and/or at later intervals during the study by: -Hunched posture, waddling/unsteady gait, lethargy, pallid extremities, walking on toes, p
- Gross pathology:
- Macroscopic examination of animals that died during the study revealed congestive changes (characterized by inflammation, darkened/pallid coloration, gaseous distension and liquid retention) in all or the majority of organs and tissues.
Macroscopic examination of animals surviving treatment and killed at study termination revealed no abnormalities.
Any other information on results incl. tables
The combined sexes slope of the probit line was 20.73 with standard error of 11.42 using log tranformation of dose. The heterogeneity factor was not significant.
The separate sexes slope of the parallel porbit lines was 22.91 with a standard error of 12.45 using log transformation of dose. The heterogeniety factor was not significant.
The chi-square test for parallelism gave no evidence of non-parallelism.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The rat oral LD50s( w/ 95% CI) were calculated to be :
Males: 1539 (1206 to 1965) mg/kg bodyweight
Females : 1373 (1174 to 1607) mg/kg bodyweight
Males and females : 1453 (1221 to 1729) mg/kg bodyweight
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.